跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 2g powder for injection vial
Approved
STANDARD
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 2g powder for injection vial
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
2a186fc2a644da4f
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
2a186fc2a644da4f
Product Name
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 2g powder for injection vial
Artg Id
277679
Artg Name
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 2 g powder for injection vial
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2017-09-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c7e613c284932bd190ac6099d2d25852.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e7a7ab4af6763aef16db9d95c8250289.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
2a186fc2a644da4f
Type
Standard
Back to TGA Approvals
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 2g powder for injection vial - TGA Drug Approval Details